Study of Niacin in Glioblastoma

NCT04677049 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
59
Enrollment
OTHER
Sponsor class

Stopped Recruitment has been placed on hold to determine evaluability of currently enrolled patients. Recruitment will remain on hold until evaluability is confirmed. If fewer than 48 evaluable patients are achieved, the study will be re-opened to accrual.

Conditions

Interventions

Sponsor

AHS Cancer Control Alberta

Collaborators